Group Statistician, ECOG-ACRIN Cancer Research Group
Robert J. Gray, PhD, is Professor of Biostatistics, Department of Biostatistics at Harvard University and Professor of Biostatistics, Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute. Dr. Gray received his PhD in Statistics from Oregon State University in 1982. He has been a member of the faculty at Harvard University since 1984 and a tenured Professor of Biostatistics since 2003.
Dr. Gray became a clinical trials statistician with the Eastern Cooperative Oncology Group (ECOG) in 1982, working primarily with its Breast Cancer Committee. He became Associate Director of the ECOG Statistical Center in 1998 and was appointed the ECOG Group Statistician in 2000. Under his leadership at the Statistical Center, ECOG has conceived and completed numerous landmark cancer clinical studies that have changed the standards of care in cancer treatment. One notable example is the Trial Assigning Individualized Options for Treatment (TAILORx), a first-of-its-kind therapeutic study that is investigating the use of the OncotypeDX® breast cancer assay to evaluate the effect of chemotherapy in women with a midrange risk of their cancer returning, as determined by the Oncotype DX Recurrence Score®.
Dr. Gray has served as the Chair of the Committee of Group Statisticians for the National Cancer Institute (NCI) since 2003 and maintains active membership in the NCI Breast Cancer Steering Committee and the Breast Cancer Intergroup Correlative Science Committee. He is a former member of the NCI Operational Efficiency Working Group and formerly served on the Steering Committee of the Clinical Trials Management System Workspace for the Cancer and Biomedical Informatics Grid (caBIG) initiative.
|Scientific Planning and Review|
|Biostatistics and Data Management|
|Active Clinical Trials|